Gosselies, Belgium, 11 September 2025 (08:30 am CET) – Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback